FDA product code CJW: Bromcresol Purple Dye-Binding, Albumin
CJW is the FDA product code for bromcresol purple dye-binding, albumin. It is a Class II device, regulated under 21 CFR 862.1035 and reviewed by the Clinical Chemistry panel. FDA has cleared 18 510(k) submissions under CJW, 1 in the last five years, from 15 different applicants. The average 510(k) review took 76 days (median 51). FDA has posted 1 recall for CJW devices.
Classification
| Field | Value |
|---|---|
| Device name | Bromcresol Purple Dye-Binding, Albumin |
| Device class | Class II |
| Regulation | 21 CFR 862.1035 |
| Review panel | CH — Clinical Chemistry |
| Medical specialty | Clinical Chemistry |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
510(k) clearances per year for CJW
| Year | Clearances | Avg. review days |
|---|---|---|
| 2019 | 1 | 52 |
| 2022 | 1 | 471 |
Compare with all 510(k) review times · Search every CJW clearance
Top CJW applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Abbott Laboratories | 3 | 1998-07-22 |
| Em Diagnostic Systems, Inc. | 2 | 1991-10-09 |
| Abbott Ireland Diagnostics Division | 1 | 2022-03-18 |
| SENTINEL CH. SpA | 1 | 2019-12-19 |
| Siemens Healthcare Diagnostics, Inc. | 1 | 2013-10-16 |
10 more applicants have CJW clearances. See the full list in Caduvo.
Most recent CJW clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K203530 | Abbott Ireland Diagnostics Division | Albumin BCP2 | 2022-03-18 | 471 |
| K193001 | SENTINEL CH. SpA | Albumin BCP | 2019-12-19 | 52 |
| K132664 | Siemens Healthcare Diagnostics, Inc. | ADVIA CHEMISTRY ALBUMIN BCP REAGENT (ALBP), ADVIA CHEMISTRY ALBUMIN BCP CALIBRATOR | 2013-10-16 | 50 |
| K021636 | Intersect Systems, Inc. | ALBUMIN REAGENT | 2002-07-17 | 61 |
| K000483 | Randox Laboratories, Ltd. | RANDOX ALBUMIN | 2000-03-31 | 46 |
Recalls for CJW devices
1 product recalls in 1 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2019-03-18.
| Year | Recalls |
|---|---|
| 2019 | 1 |
Frequently asked questions
What is FDA product code CJW?
CJW is the FDA product code for bromcresol purple dye-binding, albumin. It is a Class II device, regulated under 21 CFR 862.1035 and reviewed by the Clinical Chemistry panel.
What device class is CJW?
Class II, regulation 21 CFR 862.1035. Typical premarket route: 510(k).
How long does a 510(k) take for product code CJW?
Across 18 cleared submissions the average was 76 days from receipt to decision (median 51).
Which companies have the most CJW clearances?
Abbott Laboratories (3); Em Diagnostic Systems, Inc. (2); Abbott Ireland Diagnostics Division (1); SENTINEL CH. SpA (1); Siemens Healthcare Diagnostics, Inc. (1).
Have CJW devices been recalled?
Yes: 1 product recalls across 1 recall events; the most recent began 2019-03-18.
Next steps
- Run an FDA pathway report with predicate devices for product code CJW
- Run a recall and safety report across every CJW manufacturer
- Watch product code CJW for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times